These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31742116)

  • 21. The effect of metformin on prolactin levels in patients with drug-induced hyperprolactinemia.
    Krysiak R; Kowalcze K; Szkrobka W; Okopien B
    Eur J Intern Med; 2016 May; 30():94-98. PubMed ID: 26858210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of Serum IGF-1R, VEGF, and ET Levels with Bone Mineral Density in Type 2 Diabetic Mellitus Patients Treated with Metformin Plus
    Chen X; Li X; Kang S; Duan W
    Evid Based Complement Alternat Med; 2022; 2022():7707875. PubMed ID: 35497918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus.
    Hung YC; Lin CC; Wang TY; Chang MP; Sung FC; Chen CC
    Diabetes Metab Res Rev; 2013 Nov; 29(8):673-9. PubMed ID: 23956007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of valsartan on diabetic cardiomyopathy in rats with type 2 diabetes mellitus.
    Yang ZH; Peng XD
    Chin Med J (Engl); 2010 Dec; 123(24):3640-3. PubMed ID: 22166644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The protective effect of 1alpha, 25-dihydroxyvitamin d3 and metformin on liver in type 2 diabetic rats.
    Elattar S; Estaphan S; Mohamed EA; Elzainy A; Naguib M
    J Steroid Biochem Mol Biol; 2017 Oct; 173():235-244. PubMed ID: 27876536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function.
    Moradi N; Fadaei R; Khamseh ME; Nobakht A; Rezaei MJ; Aliakbary F; Vatannejad A; Hosseini J
    PLoS One; 2019; 14(4):e0215617. PubMed ID: 31009504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.
    Tong X; Xu J; Lian F; Yu X; Zhao Y; Xu L; Zhang M; Zhao X; Shen J; Wu S; Pang X; Tian J; Zhang C; Zhou Q; Wang L; Pang B; Chen F; Peng Z; Wang J; Zhen Z; Fang C; Li M; Chen L; Zhao L
    mBio; 2018 May; 9(3):. PubMed ID: 29789365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin in combination with rosiglitazone contribute to the increased serum adiponectin levels in people with type 2 diabetes mellitus.
    Nie JM; Li HF
    Exp Ther Med; 2017 Sep; 14(3):2521-2526. PubMed ID: 28962190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined metformin and insulin treatment reverses metabolically impaired omental adipogenesis and accumulation of 4-hydroxynonenal in obese diabetic patients.
    Jaganjac M; Almuraikhy S; Al-Khelaifi F; Al-Jaber M; Bashah M; Mazloum NA; Zarkovic K; Zarkovic N; Waeg G; Kafienah W; Elrayess MA
    Redox Biol; 2017 Aug; 12():483-490. PubMed ID: 28334683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus.
    van Lierop AH; Hamdy NA; van der Meer RW; Jonker JT; Lamb HJ; Rijzewijk LJ; Diamant M; Romijn JA; Smit JW; Papapoulos SE
    Eur J Endocrinol; 2012 Apr; 166(4):711-6. PubMed ID: 22267280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Piracetam Facilitates the Anti-Amnesic but not Anti-Diabetic Activity of Metformin in Experimentally Induced Type-2 Diabetic Encephalopathic Rats.
    Pandey S; Garabadu D
    Cell Mol Neurobiol; 2017 Jul; 37(5):791-802. PubMed ID: 27585927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies.
    Sriboonvorakul N; Pan-Ngum W; Poovorawan K; Muangnoicharoen S; Quinn LM; Tan BK
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Metformin on Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes.
    Fan H; Sun X; Zhang H; Liu J; Zhang P; Xu Y; Pan Q; Wang G
    Diabetes Technol Ther; 2016 Mar; 18(3):120-6. PubMed ID: 26950284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of testis hormonal and histopathological alterations in type I and type II diabetic rats.
    Barsiah S; Behnam-Rassouli M; Shahabipour F; Rostami S; Sabbaghi MA; Momeni Z; Tavassoli A; Sahebkar A
    J Cell Biochem; 2019 Oct; 120(10):16775-16785. PubMed ID: 31087717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin regulates atrial SK2 and SK3 expression through inhibiting the PKC/ERK signaling pathway in type 2 diabetic rats.
    Liu CH; Hua N; Fu X; Pan YL; Li B; Li XD
    BMC Cardiovasc Disord; 2018 Dec; 18(1):236. PubMed ID: 30545309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity Connected Metabolic Changes in Type 2 Diabetic Patients Treated With Metformin.
    Aleidi SM; Dahabiyeh LA; Gu X; Al Dubayee M; Alshahrani A; Benabdelkamel H; Mujammami M; Li L; Aljada A; Abdel Rahman AM
    Front Pharmacol; 2020; 11():616157. PubMed ID: 33664666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p38 MAPK Inhibitor (SB203580) and Metformin Reduces Aortic Protein Carbonyl and Inflammation in Non-obese Type 2 Diabetic Rats.
    Nokkaew N; Mongkolpathumrat P; Junsiri R; Jindaluang S; Tualamun N; Manphatthanakan N; Saleesee N; Intasang M; Sanit J; Adulyaritthikul P; Kongpol K; Kumphune S; Nernpermpisooth N
    Indian J Clin Biochem; 2021 Apr; 36(2):228-234. PubMed ID: 33867715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic actions of vitamin D and metformin on skeletal muscles and insulin resistance of type 2 diabetic rats.
    Amin SN; Hussein UK; Yassa HD; Hassan SS; Rashed LA
    J Cell Physiol; 2018 Aug; 233(8):5768-5779. PubMed ID: 29205344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.